YTS109
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for YTS109, covering 2025-12-17 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases [Phase 1]